Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Harnessing gene repression to inhibit leukemia

Developing therapeutics for cancers targeting driver mutations in epigenetic regulators is a challenging frontier in cancer therapy. A new study identifies a pathway that, when activated, inhibits the actions of the histone methyltransferase DOT1L in MLL fusion leukemia.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: MLL-AF9 fusion complexes as shown in blue and light blue activate transcription through the recruitment of the H3K79 methylase DOT1L.

References

  1. Li, B.E. & Ernst, P. Exp. Hematol. 42, 995–1012 (2014).

    CAS  Article  Google Scholar 

  2. Daigle, S.R. et al. Blood 122, 1017–1025 (2013).

    CAS  Article  Google Scholar 

  3. Chen, C.-W. et al. Nat. Med. 21, 335–343 (2015).

    CAS  Article  Google Scholar 

  4. Blander, G. & Guarente, L. Annu. Rev. Biochem. 73, 417–435 (2004).

    CAS  Article  Google Scholar 

  5. Martínez-Redondo, P. & Vaquero, A. Genes Cancer 4, 148–163 (2013).

    Article  Google Scholar 

  6. Vaquero, A. et al. Nature 450, 440–444 (2007).

    CAS  Article  Google Scholar 

  7. van Leeuwen, F., Gafken, P.R. & Gottschling, D.E. Cell 109, 745–756 (2002).

    CAS  Article  Google Scholar 

  8. Singh, S.K. et al. J. Exp. Med. 210, 987–1001 (2013).

    CAS  Article  Google Scholar 

  9. Mishra, B.P. et al. Cell Rep. 7, 1239–1247 (2014).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia Ernst.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Harte, P., Ernst, P. Harnessing gene repression to inhibit leukemia. Nat Med 21, 308–310 (2015). https://doi.org/10.1038/nm.3834

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3834

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing